$25.4B
$16.8 Million
0.01% of portfolio
616
Q2 2024
New
$160B
$15.5 Million
0.01% of portfolio
78
Q2 2024
New
$55.6B
$18 Million
0.01% of portfolio
123
Q2 2024
New
$0
$10.7 Million
0.01% of portfolio
232
Q1 2025
Reduced 10.77%
$0
$13.6 Million
0.01% of portfolio
567
Q2 2024
New
$47.1B
$15.1 Million
0.01% of portfolio
135
Q2 2024
New
$85.9B
$15.9 Million
0.01% of portfolio
72
Q2 2024
New
$0
$10.8 Million
0.01% of portfolio
181
Q2 2024
New
$0
$6.94 Million
0.01% of portfolio
67
Q1 2025
Reduced 5.63%
$18.3B
$9.31 Million
0.01% of portfolio
190
Q2 2024
New
$8.31B
$16 Million
0.01% of portfolio
300
Q2 2024
New
Gsk PLC Adr Rep 2 Corp Common
-
$11.7 Million
0.01% of portfolio
-
Q2 2025
Reduced 12.82%
$0
$6.89 Million
0.01% of portfolio
21
Q2 2024
New
$2.98B
$8.86 Million
0.01% of portfolio
442
Q2 2024
New
$0
$17.5 Million
0.01% of portfolio
464
Q2 2024
New
$0
$12.6 Million
0.01% of portfolio
135
Q2 2024
New
$0
$16.4 Million
0.01% of portfolio
188
Q2 2024
New
$30.4B
$16.1 Million
0.01% of portfolio
617
Q2 2024
New
Canadien Pacifique Kansas City Limited Canadian Pacific Corp Common
-
$18 Million
0.01% of portfolio
-
Q2 2024
New
$82.8B
$11.2 Million
0.01% of portfolio
39
Q2 2024
New
$1.95B
$10.1 Million
0.01% of portfolio
658
Q2 2024
New
$39.8B
$18.3 Million
0.01% of portfolio
388
Q4 2024
Added 38.57%
$50B
$12.4 Million
0.01% of portfolio
230
Q3 2024
Reduced 64.67%
$0
$14.4 Million
0.01% of portfolio
405
Q2 2024
New
$109B
$14.3 Million
0.01% of portfolio
257
Q1 2025
Added 59.63%
$140B
$14.6 Million
0.01% of portfolio
58
Q2 2024
New
$27.4B
$13.7 Million
0.01% of portfolio
56
Q2 2024
New
$9.3B
$11.4 Million
0.01% of portfolio
253
Q2 2024
New
$9.69B
$7.9 Million
0.01% of portfolio
306
Q2 2024
New
$0
$7.25 Million
0.01% of portfolio
65
Q2 2024
New
$94.5B
$14.3 Million
0.01% of portfolio
42
Q3 2024
New
$84B
$16.9 Million
0.01% of portfolio
88
Q4 2024
Reduced 18.52%
$0
$18.1 Million
0.01% of portfolio
144
Q2 2024
New
$0
$7 Million
0.01% of portfolio
50
Q2 2024
New
$1.9B
$10.3 Million
0.01% of portfolio
360
Q2 2024
New
$41.3B
$11.8 Million
0.01% of portfolio
141
Q2 2024
New
$12.2B
$4.01 Million
0.0% of portfolio
20
Q3 2025
New
$6.39B
$6.57 Million
0.0% of portfolio
110
Q4 2024
Added 4.76%
Rocket Lab Corp. Ordinary Shares
-
$4.79 Million
0.0% of portfolio
-
Q3 2025
New
$30B
$4.42 Million
0.0% of portfolio
17
Q2 2024
New
$21M
$390,000
0.0% of portfolio
200
Q2 2024
New
Contra Wallgreens Boots (Non Transferable Right For Cash)
-
$1,000
0.0% of portfolio
-
Q3 2025
New
$4.16B
$4.88 Million
0.0% of portfolio
260
Q3 2025
New
$37.1B
$2.01 Million
0.0% of portfolio
10
Q2 2024
New
$5.83B
$1.32 Million
0.0% of portfolio
44
Q2 2024
New
$34B
$4.56 Million
0.0% of portfolio
393
Q2 2024
New
$0
$5.88 Million
0.0% of portfolio
20
Q2 2024
New
$4.86B
$2.94 Million
0.0% of portfolio
55
Q3 2025
Reduced 90.09%
$2.97B
$709,000
0.0% of portfolio
52
Q2 2024
New
$0
$5.55 Million
0.0% of portfolio
60
Q2 2024
New